Cargando…

Structural Characterization of Human Heat Shock Protein 90 N-Terminal Domain and Its Variants K112R and K112A in Complex with a Potent 1,2,3-Triazole-Based Inhibitor

Heat shock protein 90 (Hsp90) is a ubiquitous molecular chaperone that stabilizes client proteins in a folded and functional state. It is composed of two identical and symmetrical subunits and each monomer consists of three domains, the N-terminal (NTD), the middle (MD), and the C-terminal domain (C...

Descripción completa

Detalles Bibliográficos
Autores principales: Tassone, Giusy, Mazzorana, Marco, Mangani, Stefano, Petricci, Elena, Cini, Elena, Giannini, Giuseppe, Pozzi, Cecilia, Maramai, Samuele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409116/
https://www.ncbi.nlm.nih.gov/pubmed/36012721
http://dx.doi.org/10.3390/ijms23169458
_version_ 1784774771681001472
author Tassone, Giusy
Mazzorana, Marco
Mangani, Stefano
Petricci, Elena
Cini, Elena
Giannini, Giuseppe
Pozzi, Cecilia
Maramai, Samuele
author_facet Tassone, Giusy
Mazzorana, Marco
Mangani, Stefano
Petricci, Elena
Cini, Elena
Giannini, Giuseppe
Pozzi, Cecilia
Maramai, Samuele
author_sort Tassone, Giusy
collection PubMed
description Heat shock protein 90 (Hsp90) is a ubiquitous molecular chaperone that stabilizes client proteins in a folded and functional state. It is composed of two identical and symmetrical subunits and each monomer consists of three domains, the N-terminal (NTD), the middle (MD), and the C-terminal domain (CTD). Since the chaperone activity requires ATP hydrolysis, molecules able to occupy the ATP-binding pocket in the NTD act as Hsp90 inhibitors, leading to client protein degradation and cell death. Therefore, human Hsp90 represents a validated target for developing new anticancer drugs. Since protozoan parasites use their Hsp90 to trigger important transitions between different stages of their life cycle, this protein also represents a profitable target in anti-parasite drug discovery. Nevertheless, the development of molecules able to selectively target the ATP-binding site of protozoan Hsp90 is challenging due to the high homology with the human Hsp90 NTD (hHsp90-NTD). In a previous work, a series of potent Hsp90 inhibitors based on a 1,4,5-trisubstituted 1,2,3-triazole scaffold was developed. The most promising inhibitor of the series, JMC31, showed potent Hsp90 binding and antiproliferative activity in NCI-H460 cells in the low-nanomolar range. In this work, we present the structural characterization of hHsp90-NTD in complex with JMC31 through X-ray crystallography. In addition, to elucidate the role of residue 112 on the ligand binding and its exploitability for the development of selective inhibitors, we investigated the crystal structures of hHsp90-NTD variants (K112R and K112A) in complex with JMC31.
format Online
Article
Text
id pubmed-9409116
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94091162022-08-26 Structural Characterization of Human Heat Shock Protein 90 N-Terminal Domain and Its Variants K112R and K112A in Complex with a Potent 1,2,3-Triazole-Based Inhibitor Tassone, Giusy Mazzorana, Marco Mangani, Stefano Petricci, Elena Cini, Elena Giannini, Giuseppe Pozzi, Cecilia Maramai, Samuele Int J Mol Sci Communication Heat shock protein 90 (Hsp90) is a ubiquitous molecular chaperone that stabilizes client proteins in a folded and functional state. It is composed of two identical and symmetrical subunits and each monomer consists of three domains, the N-terminal (NTD), the middle (MD), and the C-terminal domain (CTD). Since the chaperone activity requires ATP hydrolysis, molecules able to occupy the ATP-binding pocket in the NTD act as Hsp90 inhibitors, leading to client protein degradation and cell death. Therefore, human Hsp90 represents a validated target for developing new anticancer drugs. Since protozoan parasites use their Hsp90 to trigger important transitions between different stages of their life cycle, this protein also represents a profitable target in anti-parasite drug discovery. Nevertheless, the development of molecules able to selectively target the ATP-binding site of protozoan Hsp90 is challenging due to the high homology with the human Hsp90 NTD (hHsp90-NTD). In a previous work, a series of potent Hsp90 inhibitors based on a 1,4,5-trisubstituted 1,2,3-triazole scaffold was developed. The most promising inhibitor of the series, JMC31, showed potent Hsp90 binding and antiproliferative activity in NCI-H460 cells in the low-nanomolar range. In this work, we present the structural characterization of hHsp90-NTD in complex with JMC31 through X-ray crystallography. In addition, to elucidate the role of residue 112 on the ligand binding and its exploitability for the development of selective inhibitors, we investigated the crystal structures of hHsp90-NTD variants (K112R and K112A) in complex with JMC31. MDPI 2022-08-21 /pmc/articles/PMC9409116/ /pubmed/36012721 http://dx.doi.org/10.3390/ijms23169458 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Tassone, Giusy
Mazzorana, Marco
Mangani, Stefano
Petricci, Elena
Cini, Elena
Giannini, Giuseppe
Pozzi, Cecilia
Maramai, Samuele
Structural Characterization of Human Heat Shock Protein 90 N-Terminal Domain and Its Variants K112R and K112A in Complex with a Potent 1,2,3-Triazole-Based Inhibitor
title Structural Characterization of Human Heat Shock Protein 90 N-Terminal Domain and Its Variants K112R and K112A in Complex with a Potent 1,2,3-Triazole-Based Inhibitor
title_full Structural Characterization of Human Heat Shock Protein 90 N-Terminal Domain and Its Variants K112R and K112A in Complex with a Potent 1,2,3-Triazole-Based Inhibitor
title_fullStr Structural Characterization of Human Heat Shock Protein 90 N-Terminal Domain and Its Variants K112R and K112A in Complex with a Potent 1,2,3-Triazole-Based Inhibitor
title_full_unstemmed Structural Characterization of Human Heat Shock Protein 90 N-Terminal Domain and Its Variants K112R and K112A in Complex with a Potent 1,2,3-Triazole-Based Inhibitor
title_short Structural Characterization of Human Heat Shock Protein 90 N-Terminal Domain and Its Variants K112R and K112A in Complex with a Potent 1,2,3-Triazole-Based Inhibitor
title_sort structural characterization of human heat shock protein 90 n-terminal domain and its variants k112r and k112a in complex with a potent 1,2,3-triazole-based inhibitor
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409116/
https://www.ncbi.nlm.nih.gov/pubmed/36012721
http://dx.doi.org/10.3390/ijms23169458
work_keys_str_mv AT tassonegiusy structuralcharacterizationofhumanheatshockprotein90nterminaldomainanditsvariantsk112randk112aincomplexwithapotent123triazolebasedinhibitor
AT mazzoranamarco structuralcharacterizationofhumanheatshockprotein90nterminaldomainanditsvariantsk112randk112aincomplexwithapotent123triazolebasedinhibitor
AT manganistefano structuralcharacterizationofhumanheatshockprotein90nterminaldomainanditsvariantsk112randk112aincomplexwithapotent123triazolebasedinhibitor
AT petriccielena structuralcharacterizationofhumanheatshockprotein90nterminaldomainanditsvariantsk112randk112aincomplexwithapotent123triazolebasedinhibitor
AT cinielena structuralcharacterizationofhumanheatshockprotein90nterminaldomainanditsvariantsk112randk112aincomplexwithapotent123triazolebasedinhibitor
AT gianninigiuseppe structuralcharacterizationofhumanheatshockprotein90nterminaldomainanditsvariantsk112randk112aincomplexwithapotent123triazolebasedinhibitor
AT pozzicecilia structuralcharacterizationofhumanheatshockprotein90nterminaldomainanditsvariantsk112randk112aincomplexwithapotent123triazolebasedinhibitor
AT maramaisamuele structuralcharacterizationofhumanheatshockprotein90nterminaldomainanditsvariantsk112randk112aincomplexwithapotent123triazolebasedinhibitor